Results 181 to 190 of about 18,205 (239)

Central hypocretin/orexin administration alleviates sleep/wake disturbances, anhedonia, and neuroinflammation in an animal model of seasonal affective disorder. [PDF]

Ann Med
Costello A, Linning-Duffy K, Shi J, Lonstein JS, Yan L.   +4 more
europepmc   +1 more source

Insomnia and women: exploring vulnerability, impact, and intervention. [PDF]

Sleep Breath
Kim HR, Kim SI, Lim WJ, Jeong S, Ahn SH, Jeong E, Kim SY.   +6 more
europepmc   +1 more source

Orexinergic responses to environmental stressors in the zebrafish gut. [PDF]

J Comp Physiol B
Sang Y, Dixon CT, Graves CL.
europepmc   +1 more source

Single Nucleotide Polymorphisms in Orexin-1 and BDNF Receptor Genes are Associated with Increased Risk of Developing Postpartum Depression among Women with Gestational Diabetes Mellitus.

Public Health Genomics
Ghazal P, Tariq S, Munshi T.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Effects of centrally administered orexin-B and orexin-A: a role for orexin-1 receptors in orexin-B-induced hyperactivity

Psychopharmacology, 2001
Orexin-A and orexin-B are hypothalamic neuropeptides derived from a 130-amino acid precursor, prepro-orexin, and are potent agonists at both the orexin-1 (OX1) and orexin-2 (OX2) receptors. Orexin-A has been ascribed a number of in vivo functions in the rat after intracerebroventricular (ICV) administration, including hyperphagia, neuroendocrine ...
Declan N C Jones, A Johns, R A Porter
exaly   +3 more sources